866-997-4948(US-Canada Toll Free)

Polyphor Ltd - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 39 Pages

Polyphor Ltd - Product Pipeline Review - 2016

Summary

Global Markets Directs, Polyphor Ltd - Product Pipeline Review - 2016, provides an overview of the Polyphor Ltds pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Polyphor Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Polyphor Ltd
- The report provides overview of Polyphor Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Polyphor Ltds pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Polyphor Ltds out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Polyphor Ltds strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Polyphor Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Polyphor Ltds pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Polyphor Ltd Snapshot 6
Polyphor Ltd Overview 6
Key Facts 6
Polyphor Ltd - Research and Development Overview 7
Key Therapeutic Areas 7
Polyphor Ltd - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Polyphor Ltd - Pipeline Products Glance 14
Polyphor Ltd - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Polyphor Ltd - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Polyphor Ltd - Drug Profiles 18
balixafortide - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
POL-5551 - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
POL-6014 - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
POL-6926 - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
POL-7001 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
POL-7080 - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
POL-7080 Follow-On - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Small Molecules for Unspecified Indication - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
Synthetic Peptides for Unspecified Indication - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
Synthetic Peptides to Agonize FPR1/2 for Immunology and Infectious Disease - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
Synthetic Peptides to Antagonize FPR1/2 for Immunology and Infectious Disease - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
Polyphor Ltd - Pipeline Analysis 31
Polyphor Ltd - Pipeline Products by Target 31
Polyphor Ltd - Pipeline Products by Route of Administration 32
Polyphor Ltd - Pipeline Products by Molecule Type 33
Polyphor Ltd - Pipeline Products by Mechanism of Action 34
Polyphor Ltd - Dormant Projects 35
Polyphor Ltd - Discontinued Pipeline Products 36
Discontinued Pipeline Product Profiles 36
POL-7080 36
Polyphor Ltd - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

List of Tables
Polyphor Ltd, Key Facts 6
Polyphor Ltd - Pipeline by Indication, 2016 9
Polyphor Ltd - Pipeline by Stage of Development, 2016 10
Polyphor Ltd - Monotherapy Products in Pipeline, 2016 11
Polyphor Ltd - Partnered Products in Pipeline, 2016 12
Polyphor Ltd - Partnered Products/ Combination Treatment Modalities, 2016 13
Polyphor Ltd - Phase II, 2016 14
Polyphor Ltd - Phase I, 2016 15
Polyphor Ltd - Preclinical, 2016 16
Polyphor Ltd - Discovery, 2016 17
Polyphor Ltd - Pipeline by Target, 2016 31
Polyphor Ltd - Pipeline by Route of Administration, 2016 32
Polyphor Ltd - Pipeline by Molecule Type, 2016 33
Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016 34
Polyphor Ltd - Dormant Developmental Projects,2016 35
Polyphor Ltd - Discontinued Pipeline Products, 2016 36

List of Figures
Polyphor Ltd - Pipeline by Top 10 Indication, 2016 8
Polyphor Ltd - Pipeline by Stage of Development, 2016 10
Polyphor Ltd - Monotherapy Products in Pipeline, 2016 11
Polyphor Ltd - Pipeline by Target, 2016 31
Polyphor Ltd - Pipeline by Route of Administration, 2016 32
Polyphor Ltd - Pipeline by Molecule Type, 2016 33
Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016 34

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *